Evidence map›Paper›PMID 26046771›Full record

ArticlePloS one2015

Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem.

Anas Najjar, Yazan Amro, Islam Kitaneh, Salam Abu-Sharar, Maryam Sawalha, Abrar Jamous, Muhannad Qiq, Enas Makharzeh, Bayan Subb Laban, Wafa Amro and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.International journal of chronic obstructive pulmonary disease
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Anas NajjarFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Yazan AmroFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Islam KitanehFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Salam Abu-ShararFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Maryam SawalhaFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Abrar JamousFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Muhannad QiqFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Enas MakharzehFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Bayan Subb LabanFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Wafa AmroFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Ahmad AmroFaculty of Pharmacy, Al-Quds University, Jerusalem, Palestine.
Al-Quds University · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdequate patient knowledge about medications is essential for appropriate drug taking behavior and patient adherence. This study aims to assess and quantify the level of knowledge and adherence to medications among Palestinian geriatrics living with chronic diseases and to investigate possible associated socio-demographic characteristics. METHODS AND

findingsWe conducted a cross-sectional study during June 2013 and January 2014 among Palestinian geriatrics ≥ 60 years old living with chronic disease in the West Bank and East Jerusalem. A stratified random sample was selected and a questionnaire-assisted interview was applied for data collection. T-test was applied for bivariate analyzing and one-way ANOVA test was applied for multivariate analyses.

resultsA total of 1192 Palestinian geriatrics were studied. The average age was 70.3 (SD = 8.58) years and ranged from 60-110 years. The sample comprised 659 (55.3%) females and 533 (44.7%) males. The global knowledge and global adherence scores were (67.57%) and (89.29%), respectively. Adequate levels of knowledge were 71.4%, and of adherence 75%, which were recorded for 705 (59.1%) and 1088 (91.3%) participants, respectively. Significant higher levels of global knowledge and global adherence were recorded for males, and for participants who hold a Bachelor's degree, those who live on their own, and did physical activity for more than 40 hours/week (p-value < 0.05). Furthermore, workers, participants with a higher monthly income, and non-smokers have a higher knowledge level with (p-value < 0.05). We found positive correlation between participants' global adherence and global knowledge (r = 0.487 and p-value < 0.001). Negative correlation was found between participants' global knowledge and adherence with age (r = -0.236, p-value < 0.001 and r = -0.211 and p-value < 0.001, respectively. Negative correlation between global knowledge and the number of drugs taken (r = -0.130, p-value < 0.001) was predicted.

conclusionWe concluded that patients with a higher level of knowledge are more adherent to their medications and that better understanding of socio-demographic factors has a clear influence on the level of knowledge and adherence to medications and thus contributes to the development of guidelines for treatment and may consequently lead to favourable clinical outcomes and savings of health care costs.

Indexed as

Health Knowledge, Attitudes, PracticeMedication AdherenceAgedAged, 80 and overArabsChronic DiseaseCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGeriatricsHumansHypertensionIsraelMaleMiddle AgedSocial Class

Identifiers

PMID26046771
PMCPMC4457851
OpenAlexW611638444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.